AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Aug 9, 2021

30016_dirs_2021-08-09_6841ca1b-23dd-4ef2-a6b8-e01d142e47de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-05

Reporting Person: MAZELSKY JONATHAN JAY (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-05	Common Stock	M	385	—	Acquired	55605.6426	Direct
2021-08-05	Common Stock	F	179	$705.76	Disposed	55426.6426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Restricted Stock Unit	$	M	385	Disposed		Common Stock (385)	Direct

Footnotes

F1: Includes 11.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020.

F3: Not applicable.